USA - NASDAQ:SQL - US81734C3043 - Common Stock
The current stock price of SQL is 6.5991 USD. In the past month the price decreased by -58.1%. In the past year, price decreased by -63.02%.
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| TMO | THERMO FISHER SCIENTIFIC INC | 25.9 | 219.06B | ||
| DHR | DANAHER CORP | 28.69 | 158.39B | ||
| BRKRP | BRUKER CORP - BRKR 6 3/8 09/01/28 | 167.64 | 50.87B | ||
| A | AGILENT TECHNOLOGIES INC | 26.95 | 41.64B | ||
| IQV | IQVIA HOLDINGS INC | 19.22 | 38.00B | ||
| MTD | METTLER-TOLEDO INTERNATIONAL | 33.75 | 29.09B | ||
| WAT | WATERS CORP | 29.87 | 22.58B | ||
| WST | WEST PHARMACEUTICAL SERVICES | 37.72 | 19.18B | ||
| ILMN | ILLUMINA INC | 27.51 | 18.43B | ||
| MEDP | MEDPACE HOLDINGS INC | 41.35 | 16.61B | ||
| TEM | TEMPUS AI INC | N/A | 11.80B | ||
| RVTY | REVVITY INC | 19.5 | 10.84B |
SeqLL Inc is a US-based company operating in Life Sciences Tools & Services industry. The company is headquartered in Woburn, Massachusetts and currently employs 7 full-time employees. The company went IPO on 2021-08-27. SeqLL Inc. (SeqLL) is a life sciences instrumentation and research services company that is engaged in the development of scientific assets and intellectual property across multiple omics fields. The firm is engaged in the design, development and manufacturing of genetic analysis technologies. The company leverages its True Single Molecule Sequencing (tSMS) technology, which enables researchers and clinicians to contribute advancements to scientific research and development. Its tSMS platform offers a single molecule solution for deoxyribonucleic acid (DNA) and ribonucleic acid (RNA) sequencing by performing detection of nucleic acids without the need for complex sample manipulation. Researchers using its platform can analyze billions of single molecules in a single experiment and generate reproducible data. Its single molecule platform combines a fluorescence-based optical detection apparatus with a precision microfluidics and thermal control system to perform sequencing-by-synthesis.
SEQLL INC
317 New Boston St Ste 210
Woburn MASSACHUSETTS US
CEO: Daniel Jones
Employees: 7
Phone: 17818173755.0
SeqLL Inc is a US-based company operating in Life Sciences Tools & Services industry. The company is headquartered in Woburn, Massachusetts and currently employs 7 full-time employees. The company went IPO on 2021-08-27. SeqLL Inc. (SeqLL) is a life sciences instrumentation and research services company that is engaged in the development of scientific assets and intellectual property across multiple omics fields. The firm is engaged in the design, development and manufacturing of genetic analysis technologies. The company leverages its True Single Molecule Sequencing (tSMS) technology, which enables researchers and clinicians to contribute advancements to scientific research and development. Its tSMS platform offers a single molecule solution for deoxyribonucleic acid (DNA) and ribonucleic acid (RNA) sequencing by performing detection of nucleic acids without the need for complex sample manipulation. Researchers using its platform can analyze billions of single molecules in a single experiment and generate reproducible data. Its single molecule platform combines a fluorescence-based optical detection apparatus with a precision microfluidics and thermal control system to perform sequencing-by-synthesis.
The current stock price of SQL is 6.5991 USD. The price decreased by -20.2% in the last trading session.
SQL does not pay a dividend.
SQL has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
SEQLL INC (SQL) operates in the Health Care sector and the Life Sciences Tools & Services industry.
SEQLL INC (SQL) currently has 7 employees.
ChartMill assigns a fundamental rating of 2 / 10 to SQL. SQL scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.
Over the last trailing twelve months SQL reported a non-GAAP Earnings per Share(EPS) of -13.6. The EPS decreased by -3588.5% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -79.09% | ||
| ROE | -181.2% | ||
| Debt/Equity | 0.5 |
5 analysts have analysed SQL and the average price target is 3.06 USD. This implies a price decrease of -53.63% is expected in the next year compared to the current price of 6.5991.
For the next year, analysts expect an EPS growth of 96.95% and a revenue growth -100% for SQL